Solving Alzheimer’s
Alzheimer’s disease currently affects 5.3 million Americans, and one more is added to the list every 70 seconds. That’s why it’s so critical that research continue, and why it was such a blow to families worldwide when Eli Lilly and Co. announced it would halt development of Semagacestat, its promising treatment for Alzheimer’s. Phase III […]